Watch the video highlights

Insights from immunization coalition experts and analysis of successful immunization coalitions

Investing in science and innovation is one of six key areas of development needed to prepare for future pandemics, according to a new report conducted by the International Pharmaceutical Federation (FIP).

The European Public Health Alliance have signed a memorandum of understanding with WHO Europe to enhance their partnership. Both organisations will work closely to address key health challenges and drive positive change.

Why should older adults be particularly careful of acute respiratory viruses? What are risk factors for adverse outcomes? Why is RSV typically under-diagnosed in adults compared with flu and what are some of the long-term impacts?

The shocking numbers of babies and children who die, or who are in need of care, coupled with the rising number of undiagnosed older adults puts a significant burden from RSV on health systems.

It provides an overview of the project results at the end of 2 years of collaborative work: the training tools and resources designed to support health professionals in their vaccine communication efforts and the advocacy campaigns.

Pandemic Action Network releases a policy paper with a set of recommendations to establish ​​a new equitable, effective, and efficient pandemic countermeasures platform that will be key in responding to future health threats.